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There is a good chance that most physi cians will have seen a patient with an immune deficiency in the past year. This brief review aims to help decide when a patient needs to be investigated for immunodeficiency, what tests should be done and what to do with the results. Detailed descriptions of individual immunodeficiency disorders can be found in reviews listed. [1] [2] [3] Children with suspected immunodeficiency require special consideration and are outside the scope of this article.
Epidemiology and missed diagnoses
HIV infection is the most common cause of secondary immunodeficiency for which prevalence data are available. It is estimated that 0.2% of men and 0.1% of women in the UK are infected, approxi mately one-quarter of them undiag nosed. 4 Neutropenia and other secondary and iatrogenic immunodeficiencies are common but their prevalence is difficult to quantify. The prevalence of common vari able immunodeficiency (CVID), the most common primary antibody deficiency, is at least one in 50,000 in the UK but it is likely that many cases are unknown. International estimates of prevalence of CVID are as high as one in 10,000. Selective immunoglobulin A deficiency is common (1 in 500-700) but most of these individuals are asymptomatic and do not suffer from infections. Complement, pri mary T lymphocyte and neutrophil disor ders are relatively rare.
There is also a significant delay in the diagnosis of immunodeficiency: 52% of adults with HIV infection are diagnosed late and 30% very late. In primary anti body deficiencies, delays of over seven years between first presentation and final diagnosis are common. For both diseases patients have often been reviewed by sev eral physicians without the diagnosis having been considered. Delays in diag nosis and treatment are associated with poor outcomes.
Key points
Patients with immunodeficiency often present with infections but these need not be unusual or severe Immunodeficiency presenting in adults may be secondary (eg HIV, lymphoma, drugs) or primary (usually antibody deficiency) FISHing (full blood count, immunoglobulins, serum complement, HIV test) will identify the most common immunodeficiencies Adults with normal initial investigations may nonetheless have significant immunodeficiency: referral to an immunologist is recommended where there is a high index of suspicion some anticonvulsants and antirheumatic drugs (eg sulphazalazine, gold). With some newer biological agents (eg antitu mour necrosis factor drugs, rituximab), the infection risk may not be fully recog nised for many years after they are licensed.
Contrary to common perception, pri mary immunodeficiency often presents for the first time in adulthood. Recent UK guidelines for bronchiectasis specif ically recommend testing for immunod eficiency in all cases. Other conditions such as sarcoid (or other granulomatous conditions), inflammatory bowel dis ease, lymphoma, immune thrombocy topenic purpura and neutropenia should also trigger immunodeficiency investigations.
Sometimes it is not the infection itself but the associated features which should prompt consideration of immunodefi ciency. Paradoxically, autoimmunity is increased in immunodeficiency. Infections occurring in patients with splenomegaly, cytopenias (neutrophils, lymphocytes or platelets), chronic diar rhoea, sarcoid or coeliac disease should be investigated further (Fig 1) .
While recurrent meningitis is the hall mark of complement deficiency, not all complement disorders present with
When should immunodeficiency be considered?
Immunodeficiency should always be con sidered in patients with severe, persistent, unusual or recurrent infections. HIV testing should be specifically offered in a range of common conditions, including tuberculosis, atypical pneumonia, lym phoma, hepatitis B and C infection, as well as with well-known AIDS-defining ill nesses (Kaposi's sarcoma, pneumocystis, cryptococcal or toxoplasma infections and oesophageal candida). In such circum stances, if HIV tests are negative, wider screening for immunodeficiency is often warranted. Infections and other presenta tions that should cause concern are included in Table 1 
Laboratory investigations
Laboratory evidence of immunodefi ciency may be identified indirectly during the course of routine testing for vague clinical presentations. Neutropenia, and especially lym phopenia, are often ignored or attributed to other causes and not further investi gated. Low serum globulins (total pro tein minus albumin should be �20 g/l) may be seen in hypogammaglobuli naemia. Similarly raised globulins (�40 g/l) can occur in HIV infection and myeloma and should prompt further tests. Failure to produce an antibody response to vaccination or infection, or absent isohaemagglutinins (blood group antibodies) may also be pointers to anti body deficiency.
Testing for immunodeficiency: go 'FISHing'
The tests indicated depend on the most likely diagnosis. This is suggested by a combination of the presenting features and prevalence of the condition. For example, meningococcal meningitis is a classic presentation of a complement deficiency, but antibody deficiencies are more likely to be identified because they are commoner. Fortunately, the most common immunodeficiencies can be identified on simple and widely available tests. In a busy clinical environment, the acronym FISH (full blood count, immunogloblins, serum complement C3/C4, HIV test) is a mnemonic for the common first-line investigations. These initial tests are occasionally diagnostic but usually only provide pointers to the problem (Table 2a) . Scrutiny of the results with follow-up of any abnor mality is essential (Table 2b) .
Further investigations
A comprehensive algorithm for investiga tion of immunodeficiency has been pub lished 5 and is also available as a web-based tool (www.ukpin.org.uk). Discussion with an immunologist is recommended for cases where abnormalities of uncertain sig nificance are found or immunodeficiency is strongly suspected despite normal inves tigations. 6 Immunodeficiency disorders not identified on routinely available tests include specific antibody deficiency, com plement deficiency, chronic granuloma tous disease or type 1 cytokine deficiency. These can be identified only by requesting the specific diagnostic test on the basis of a high index of suspicion and knowledge of the typical presentations of the individual diseases.
When the investigation of immunode ficiency is being considered, discussion of appropriate microbiological investiga tions should take place at the same time. Specialised culture or molecular tests for a wider range of organisms may be indi cated. It is worth noting that viral and bacterial serology will be unreliable in patients with antibody deficiency. Similarly, interferon-gamma release assays (eg to investigate tuberculosis) may also be falsely negative in immuno suppressed patients. Finally, some patients clearly have abnormal susceptibility to infection but do not fall into any currently known disease pattern. These patients should be referred for immunology specialist follow-up. It is in this environment that rare and new dis eases will continue to be investigated, and where the interface of the basic science and clinical practice of immunology helps to advance understanding and therapy of the immune system.
Conclusions
The question 'Does this patient have an immune deficiency?' should be asked in a wide range of clinical scenarios in which infection need not be a prominent feature. The situation is analogous to cystic fibrosis, coeliac or thyroid disease which are increasingly diagnosed in patients who lack the classic features of the condition. Widely available, simple tests can often suggest the diagnosis, but further tests and specialist referral are indicated where there is a high index of suspicion. There remains a perception that HIV testing is awkward and patients (and many doctors) still avoid discussing it. Until the HIV test becomes an 'ordinary' investigation in routine practice, this condition will remain underdiagnosed to the detriment of the patient and the public. We recommend 
